{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T23:05:59Z","timestamp":1766012759327,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"55","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicine - Programa de Formaci\u00f3n M\u00e9dica Continuada Acreditado"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.med.2022.05.003","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T16:38:10Z","timestamp":1652373490000},"page":"3224-3234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neumon\u00eda v\u00edrica. Neumon\u00eda en la COVID-19"],"prefix":"10.1016","volume":"13","author":[{"given":"D. Alonso","family":"Mench\u00e9n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Balsa","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M. Barbero","family":"Allende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Hern\u00e1ndez","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.med.2022.05.003_bib0005","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.rmed.2016.11.023","article-title":"Viruses are prevalent in non-ventilated hospital-acquired pneumonia","volume":"122","author":"fx7 Shorr","year":"2017","journal-title":"Respir Med."},{"issue":"5","key":"10.1016\/j.med.2022.05.003_bib0010","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among U.S. Adults","volume":"373","author":"fx7 fx1 Jain","year":"2015","journal-title":"N Engl J Med."},{"issue":"10303","key":"10.1016\/j.med.2022.05.003_bib0015","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(21)00630-9","article-title":"Community-acquired pneumonia","volume":"398","author":"fx4 fx2 Aliberti","year":"2021","journal-title":"Lancet."},{"key":"10.1016\/j.med.2022.05.003_bib0020","first-page":"1","article-title":"Viral pneumonia: etiologies and treatment","volume":"0","author":"fx4 Dandachi","year":"2018","journal-title":"J Investig Med."},{"issue":"3","key":"10.1016\/j.med.2022.05.003_bib0025","doi-asserted-by":"crossref","first-page":"115246","DOI":"10.1016\/j.diagmicrobio.2020.115246","article-title":"Enhanced detection of community-acquired pneumonia pathogens with the BioFire\u00aePneumonia FilmArray\u00aePanel","volume":"99","author":"fx5 Gilbert","year":"2021","journal-title":"J Diagn Microbiol Infect Dis."},{"issue":"4","key":"10.1016\/j.med.2022.05.003_bib0030","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/infdis\/jiv323","article-title":"Respiratory viral detection in children and adults: Comparing asymptomatic controls and patients with community-acquired pneumonia","volume":"213","author":"fx5 Self","year":"2016","journal-title":"J Infect Dis."},{"issue":"8","key":"10.1016\/j.med.2022.05.003_bib0035","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/cid\/cit471","article-title":"High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections","volume":"57","author":"fx5 Lee","year":"2013","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.med.2022.05.003_bib0040","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1086\/339881","article-title":"Rhinovirus and coronavirus infection\u2013associated hospitalizations among older adults","volume":"185","author":"fx5 Falsey","year":"2002","journal-title":"J Infect Dis."},{"issue":"5","key":"10.1016\/j.med.2022.05.003_bib0045","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1073\/pnas.1716561115","article-title":"EMIT Consortium. Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community","volume":"115","author":"fx5 Yan","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1016\/j.med.2022.05.003_bib0050","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12879-015-1004-y","article-title":"Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection\u2014United States, 2005-2008","volume":"15","author":"fx7 Garg","year":"2015","journal-title":"BMC Infect Dis."},{"issue":"5","key":"10.1016\/j.med.2022.05.003_bib0055","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/irv.12398","article-title":"The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis","volume":"10","author":"fx3 Klein","year":"2016","journal-title":"Influenza Other Respir Viruses."},{"issue":"6","key":"10.1016\/j.med.2022.05.003_bib0060","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciy866","article-title":"Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa","volume":"68","author":"fx6 fx1 Uyeki","year":"2019","journal-title":"Clin Infect Dis."},{"issue":"5","key":"10.1016\/j.med.2022.05.003_bib0065","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1086\/650458","article-title":"Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus","volume":"50","author":"fx5 Ng","year":"2010","journal-title":"Clin Infect Dis."},{"issue":"9","key":"10.1016\/j.med.2022.05.003_bib0070","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1086\/344319","article-title":"Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups","volume":"186","author":"fx7 Boivin","year":"2002","journal-title":"J Infect Dis."},{"issue":"9","key":"10.1016\/j.med.2022.05.003_bib0075","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/cid\/cix528","article-title":"Parainfluenza Virus in the Hospitalized Adult","volume":"65","author":"fx4 Russell","year":"2017","journal-title":"Clin Infect Dis."},{"issue":"2","key":"10.1016\/j.med.2022.05.003_bib0080","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jinf.2020.05.046","article-title":"Co-infections in people with COVID-19: a systematic review and meta-analysis","volume":"81","author":"fx3 Lansbury","year":"2020","journal-title":"J Infect."},{"issue":"4","key":"10.1016\/j.med.2022.05.003_bib0085","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/emp2.12128","article-title":"Viral and atypical respiratory co-infections in COVID-19: a systematic review and meta-analysis","volume":"1","author":"fx3 Davis","year":"2020","journal-title":"J Am Coll Emerg Physicians Open."},{"issue":"13","key":"10.1016\/j.med.2022.05.003_bib0090","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72?314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"fx7 fx1 Wu","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.med.2022.05.003_bib0095","unstructured":"fx4 fx1 Actualizaci\u00f3n n\u00b0 105. Enfermedad por el coronavirus (COVID-19). 14.05.2020, Ministerio de Sanidad."},{"issue":"11","key":"10.1016\/j.med.2022.05.003_bib0100","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.cmi.2020.07.024","article-title":"COVID-19@Spain Study Group; Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain","volume":"26","author":"fx7 fx2 Berenguer","year":"2020","journal-title":"Clin Microbiol Infect."},{"issue":"3","key":"10.1016\/j.med.2022.05.003_bib0105","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"fx7 Liu","year":"2020","journal-title":"Sci China Life Sci."},{"issue":"2","key":"10.1016\/j.med.2022.05.003_bib0110","first-page":"327","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"fx4 Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents."},{"issue":"10229","key":"10.1016\/j.med.2022.05.003_bib0115","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan. China: a retrospective cohort study","volume":"28","author":"fx7 Zhou","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.med.2022.05.003_bib0120","doi-asserted-by":"crossref","unstructured":"fx7 Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, the Northwell COVID-19 Research Consortium, Barnaby DP, Becker LB, Chelico JD, Cohen SL, Cookingham J, Coppa K, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020; 323(20):2052.","DOI":"10.1001\/jama.2020.6775"},{"key":"10.1016\/j.med.2022.05.003_bib0125","unstructured":"fx7 Centers for Disease Control and Prevention. Science brief: Evidence used to update the list of underlying medical conditions that increase a person's risk of severe illness from COVID-19. Disponible en: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/clinical-care\/underlying-evidence-table.html [Consultado Ago 2021]."},{"key":"10.1016\/j.med.2022.05.003_bib0130","unstructured":"fx4 Informaci\u00f3n cient\u00edfica-t\u00e9cnica. Enfermedad por coronavirus, COVID-19. Ministerio de Sanidad. Centro de Coordinaci\u00f3n de Alertas y Emergencias Sanitarias. Actualizaci\u00f3n, 15 de enero 2021."},{"key":"10.1016\/j.med.2022.05.003_bib0135","doi-asserted-by":"crossref","first-page":"m1443","DOI":"10.1136\/bmj.m1443","article-title":"Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China. January-March 2020: retrospective cohort study","volume":"369","author":"fx5 Zheng","year":"2020","journal-title":"BMJ."},{"issue":"5","key":"10.1016\/j.med.2022.05.003_bib0140","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.cmi.2021.02.001","article-title":"Spanish Panbio\u2122 COVID-19 validation group. Multicenter evaluation of the Panbio\u2122 COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection","volume":"27","author":"fx5 Merino","year":"2021","journal-title":"Clin Microbiol Infect."},{"issue":"22","key":"10.1016\/j.med.2022.05.003_bib0145","first-page":"e120","article-title":"Rethinking Covid-19 test sensitivity - a strategy for containment","volume":"383","author":"fx4 Mina","year":"2020","journal-title":"N Engl J Med."},{"issue":"22","key":"10.1016\/j.med.2022.05.003_bib0150","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1001\/jama.2020.8259","article-title":"Interpreting diagnostic tests for SARS-CoV-2","volume":"323","author":"fx4 fx1 Sethuraman","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.med.2022.05.003_bib0155","unstructured":"fx6 fx1 CDC Interim Guidelines for COVID-19 Antibody Testing in Clinical and Public Health Settings Updated Mar. 17, 2021."},{"issue":"3","key":"10.1016\/j.med.2022.05.003_bib0160","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/bloodadvances.2020003763","article-title":"American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19","volume":"5","author":"fx6 Cuker","year":"2021","journal-title":"HJ Blood Adv."},{"key":"10.1016\/j.med.2022.05.003_bib0165","doi-asserted-by":"crossref","unstructured":"fx5 ATTACC Investigators; ACTIV-4a Investigators; REMAP-CAP Investigators. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med. 2021; 385(9):790-802.","DOI":"10.1056\/NEJMoa2105911"},{"key":"10.1016\/j.med.2022.05.003_bib0170","doi-asserted-by":"crossref","unstructured":"fx5 fx1 WHO Solidarity Trial Consortium, Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, Abdool Karim Q, et al. Repurposed antiviral drugs for Covid-19 - Interim WHO Solidarity Trial Results. N Engl J Med. 2021; 384(6):497-511.","DOI":"10.1056\/NEJMoa2023184"},{"issue":"19","key":"10.1016\/j.med.2022.05.003_bib0175","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"ACTT-1 Study Group Members. Remdesivir for the Treatment of Covid-19 - Final Report","volume":"383","author":"fx5 fx2 Beigel","year":"2020","journal-title":"N Engl J Med."},{"issue":"13","key":"10.1016\/j.med.2022.05.003_bib0180","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1001\/jama.2020.16747","article-title":"Corticosteroids in COVID-19 ARDS: Evidence and hope during the pandemic","volume":"324","author":"fx4 fx1 Prescott","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.med.2022.05.003_bib0185","doi-asserted-by":"crossref","unstructured":"fx3 WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne JAC, Sterne JAC, Murthy S, Diaz JV, et al. Association between administration of systemic corticosteroids and mortality among critically Ill patients with COVID-19: A meta-analysis. JAMA. 2020; 324:1330-41.","DOI":"10.1001\/jama.2020.17023"},{"key":"10.1016\/j.med.2022.05.003_bib0190","doi-asserted-by":"crossref","unstructured":"fx5 RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021; 384(8):693-704.","DOI":"10.1056\/NEJMoa2021436"},{"key":"10.1016\/j.med.2022.05.003_bib0195","doi-asserted-by":"crossref","unstructured":"fx5 fx2 RECOVERY Collaborative Group. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021; 397(10285):1637-45.","DOI":"10.1016\/S0140-6736(21)00676-0"},{"key":"10.1016\/j.med.2022.05.003_bib0200","doi-asserted-by":"crossref","unstructured":"fx5 fx2 REMAP-CAP Investigators, Gordon AC, Mouncey PR, Al-Beidh F, Rowan KM, Nichol AD, Arabi YM, et al. Interleukin-6 receptor antagonists in critically ill patients with Covid-19. N Engl J Med. 2021; 384(16):1491-502.","DOI":"10.1056\/NEJMoa2100433"},{"issue":"2","key":"10.1016\/j.med.2022.05.003_bib0205","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1056\/NEJMsr2105280","article-title":"SARS-CoV-2 variants and vaccines","volume":"385","author":"fx4 Krause","year":"2021","journal-title":"N Engl J Med."}],"container-title":["Medicine - Programa de Formaci\u00f3n M\u00e9dica Continuada Acreditado"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304541222001159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304541222001159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T06:27:48Z","timestamp":1759645668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304541222001159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":41,"journal-issue":{"issue":"55","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0304541222001159"],"URL":"https:\/\/doi.org\/10.1016\/j.med.2022.05.003","relation":{},"ISSN":["0304-5412"],"issn-type":[{"type":"print","value":"0304-5412"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neumon\u00eda v\u00edrica. Neumon\u00eda en la COVID-19","name":"articletitle","label":"Article Title"},{"value":"Medicine - Programa de Formaci\u00f3n M\u00e9dica Continuada Acreditado","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.med.2022.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}